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Abstract 
Context: Asthma is the most common inflammatory disease of the airways in children. The term 
problematic asthma is used to describe children with chronic symptoms or acute severe exacerbations, or 
both, not responding to standard asthma therapy.  
Case Presentation: We describe the case of a 5 years old girl with a history of recurrent respiratory 
infections and asthma since the first months of life, with a poor response to conventional therapies 
(antibiotics, high dose corticosteroids combined with long-acting β2 agonists and oral leukotriene-receptor 
antagonists). In some cases she needed hospitalization for the important respiratory engagement and 
radiological findings of pulmonary consolidations, predominantly localized to the right lung. Computed 
tomography angiography (CTA), described a mild tracheobronchomalacia caused by the right innominate 
artery compression and a dense tissue mediastinal extrinsic compression of the main bronchus of the 
middle lobe, defined a Middle Lobe Syndrome (MLS).  
Evidence Acquisition: MLS is defined as a recurrent or chronic collapse or infection of the middle lobe of 
the right lung. There is often a history of multiple treatments with antibiotics and anti-asthmatic drugs for 
‘‘recurrent pneumonia’’ or ‘‘asthma’’, as in our patient. Chest X-ray is the first-line diagnostic tool, 
especially on the lateral view. CT-scan and bronchoscopy are considered useful for diagnosis or treatment. 
Treatment depends on etiology of MLS.  
Conclusion: In case of severe asthma symptoms co-morbidities must be evaluated. MLS is frequently 
unrecognized in children and thinking of it is a prerequisite for diagnosis, especially when recurrent 
respiratory infections or asthma symptoms are predominantly localized to the right lung.  
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Introduction 
Asthma is the most common inflammatory disease of the airways in children characterized by 
period of reversible airflow obstruction and increased bronchial reactivity to nonspecific stimuli.  
Among children current asthma prevalence is about 10%.  Asthma episodes may be mild or 
moderate and can be controlled by traditional asthma therapies according to International 
Guidelines. However, less than 5% of patients has a severe asthmatic disease.(1). 
 Severe asthma can be defined as the American Thoracic Society stated in 2000 when one of two 
major criteria (1. Continuous intake of high-dose inhaled steroids; 2.taking oral steroids -OCS- 
for more than six months during the previous year) and at least two of seven minor criteria 
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pulmonary, function tests, freque
use of health facilities, are fulfilled.(1)
The term of problematic asthma was first used by Bush et al.
chronic symptoms or acute severe exacerbations
therapy. The exact prevalence of this population is difficult to estimate, but the atopy is almost 
always present.(3, 4) The assessment of these children should be obtained through a systematic 
protocol. The initial step is to ensure that a wrong diagnosis has not been made (“not asthma at 
all”); and next to evaluate co
multidisciplinary assessment to develop the best individualized treatment.
Case Report. 
We describe the case of a 5 years old girl. She had been born at full
complications. Weight and length were adequate for gestational age at birth. The patient was 
breast-fed exclusively for one month. Her mother and brother had a hi
rhinitis during childhood. Since the early months of life she suffered from recurrent airway 
infections and asthma. The episodes often have a severe course and in some cases she needed 
hospitalization for the important respirat
inflammatory markers (neutrophilic leukocytosis and high values of c
hematological tests and radiological findings of pulmonary consolidations, predominantly 
localized to the right lung.  . She was treated with short
acute severe asthma or suspected pneumonia, and traditional maintenance therapy asthma using an anti
static valved holding chamber (CSI combined with long
antagonists) with poor benefit. Therefore our patient had undergone careful systematic protocol to exclude 
other diagnostic hypotheses. Skin Prick Test and IgEs were mild positive for house dust mites and Grass 
pollen. Throat swab, blood culture, Mantoux test
Chlamidia Pneumonia serological tests were normal.
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ncy of exacerbations, disease stability at reductions of therapy, 
  
 (2) in 2008 to describe children with 
, or both, not responding to standard asthma 
-morbidities (“asthma plus”). The next step is a detailed 
 
-term gestation, without 
story of asthma and allergic 
ory engagement. In these occasions we underlined high 
-reactive protein) on 
-acting β2 agonists and antibiotics, in cases of 
-acting β2 agonists and oral leukotriene
,, QuantiFERON test and viruses, Mycoplasma and 
 
Immunodeficiency disorders, Cystic Fibrosis and Ciliary 
Dyskinesia were excluded. 
An esophago-gastro-duodenal transit st
During exacerbations chest X-ray on the lateral view 
showed a wedge-shaped opacity bordered by the 
horizontal and oblique fissures (Figure1).
Computed Tomography Angiography (CTA) described a 
mild tracheobronchomalacia caused by the
innominate artery compression and the bronchomalacia 
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and stenosis of the main bronchus of the middle lobe determined by a dense tissue mediastinal 
extrinsic compression, associated with right middle lobe atelectasis. (Figure2) 
Radiological findings described a condition of tracheobronchomalacia and Middle Lobe 
Syndrome. In clinical health condition the airway endoscopy confirmed the anatomical 
malformations CT-scan revealed. The cytological and culture study of BAL
inflammatory cellularity with few fat macrophages and positivity for H. Influenzae type B 
(1.000.000 UFC/mL). 
Discussion 
Middle Lobe Syndrome (MLS) is long been recognized in literature as a specific clinical and 
radiographic entity, defined as a recur
the right lung. The process can also occur in other areas of the lung, particularly in the lingula.(5) 
The exact prevalence of MLS is unknown, it can occur in all age groups, but it is more freque
in preschool years and girls are interest twice as often than boys. (5, 7)
traditionally classified into obstructive and nonobstructive, but pathophysiologic mechanisms can 
occasionally interact. (Table 1). 
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Obstructive MLS can be caused by extrinsic 
compression of the middle lobe bronchus or by 
endobronchial lesions.  
In the nonobstructive type of MLS, the middle 
lobe bronchus is susceptible to collapse for 
several anatomical as well as functional factors: 
the narrow diameter and long length of the 
middle lobe bronchus, the deep fissures of the 
middle lobe with only scanty parenchymal 
bridges which determine a relative anatomical 
isolation, the crown arrangement of lymph 
nodes around the middle bronchus, and finally 
the poor development of the inter-alveolar 
pores of Kohn in early life.(5, 7). The MLS 
clinical presentation is characterized by 
nonspecific respiratory symptoms, such as 
chronic or recurrent cough, intermittent 
wheezing, and recurrent or persistent 
pneumonia. 
 
Table 1 Romagnoli et al. (2014) Middle lobe syndrome in children 
today.  PaediatrRespirRev;15.1883. 
doi:10.1016/j.prrv.2014. 01.002.Epub2014Jan31 
 
It also may present as asymptomatic, so it leads to delayed or frequently unrecognized diagnosis 
in children. There is often a history of multiple treatments with antibiotics and anti-asthmatic 
drugs for ‘‘recurrent pneumonia’’ or ‘‘asthma”, as in our patient. Indeed asthma may be 
frequently associated with MLS and when a viral infection occurs in an asthmatic patient, 
inflammation can occlude the lumen of the right middle bronchus, causing partial or complete 
obstruction. Chest X-ray is the first-line diagnostic tool, especially on the lateral view. In recent 
years CT-scan and bronchoscopy are considered useful for diagnosis or treatment, the first to 
identify endobronchial abnormalities, bronchiectasis and other parenchymal abnormalities, the 
second is often therapeutic in acute or chronic phase (foreign body aspiration or mucus plugs 
removal). Bronchoalveolar lavage can be concurrently performed to determine cellular elements 
and infection signs. Treatment depends on causes of MLS.  
Conservative intervention should be the first-line, using anti-asthmatic therapy and antibiotics 
agents, only if bacterial infection is present or suspected. Chest-physiotherapy adds on aerosol-
therapy by inhalation of jet-nebulized saline increases sputum volume and clearance. There is no 
consensus regarding the indication for surgical intervention in MLS, especially in children.(5) 
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Children with right middle lobe syndrome unresponsive to medical treatment should undergo 
early lobe resection to avoid serious complications and the progression of the disease to other 
segments or lobes.(8)  
In conclusion, we describe a case of severe asthma worsen by the presence of 
tracheobronchomalacia and Middle Lobe Syndrome. Actually she is treated with maintenance 
therapy (CSI and oral leukotriene-receptor antagonists) and short-acting β2 agonists and 
antibiotics, only if acute asthma or bacterial infection are present or suspected respectively. She 
also practices physiotherapy with PEEP-mask twice a day and Continuous-Positive-Airway-
Pressure ventilation therapy during the night for the major risk of the airway collapse and sleep 
apnea during the night. She is monitored in clinic every three months. 
Thinking of MLS is a prerequisite for diagnosis, especially when there is a history of recurrent 
respiratory infections or asthma, and when clinical or radiological findings are predominantly 
localized to the right lung. Chest X-ray is the first-line diagnostic tool, and the lateral view should 
be requested.  
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